Original language | English |
---|---|
Pages (from-to) | 999 |
Number of pages | 1 |
Journal | Journal of Pharmacology and Experimental Therapeutics |
Volume | 326 |
Issue number | 3 |
State | Published - Sep 2008 |
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)- 3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats (Journal of Pharmacology anf Experimantal Therapeutics (2008) 326, (218-229))
S. G. Lehto, R. Tamir, H. Deng, L. Klionsky, R. Kuang, A. Le, D. Lee, J. C. Louis, E. Magal, B. H. Manning, R. Rubino, S. Surapaneni, N. Tamayo, T. Wang, J. Wang, J. Wang, W. Wang, B. Youngblood, M. Zhang, D. Zhu
Research output: Contribution to journal › Comment/debate
3
Scopus
citations